Status:
COMPLETED
The Effect of Dietary Lauric Acid on the Production of the LRH-1 Ligand, Dilauroylphosphatidylcholine
Lead Sponsor:
Cornell University
Conditions:
Diet Modification
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
A phosphatidylcholine species enriched with lauric acid at both the sn-1 and sn-2 positions, dilauroylphosphatidylcholine (DLPC), was recently identified as a ligand for the nuclear receptor, liver re...
Detailed Description
A phosphatidylcholine species enriched with lauric acid at both the sn-1 and sn-2 positions, dilauroylphosphatidylcholine (DLPC), was recently identified as a ligand for the nuclear receptor, liver re...
Eligibility Criteria
Inclusion
- Willingness to comply with the study protocol
- Ability to overnight fast
- Willingness to donate blood
- 'generally healthy'
Exclusion
- self-reported regular consumption of tropical oils or supplements containing lauric acid
- self-reported food allergies to shake ingredients
- medical conditions where blood draws or fasting may be contraindicated
- major gastrointestinal conditions, such as inflammatory bowel disease
Key Trial Info
Start Date :
March 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 22 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03481608
Start Date
March 19 2018
End Date
April 22 2018
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Human Metabolic Research Unit, Cornell University
Ithaca, New York, United States, 14853